Precision Medicine Using Pharmacogenomic Panel-Testing Current Status and Future Perspectives

被引:3
作者
van der Wouden, Cathelijne H. [1 ,2 ]
Guchelaar, Henk-Jan [1 ,2 ]
Swen, Jesse J. [1 ,2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
[2] Leiden Network Personalised Therapeut, Leiden, Netherlands
关键词
Pharmacogenomics; Panel-testing; Implementation; Adverse drug reactions; DNA REFERENCE MATERIALS; PERSONALIZED MEDICINE; IMPLEMENTING PHARMACOGENOMICS; CLINICAL IMPLEMENTATION; DECISION-SUPPORT; RANDOMIZED-TRIAL; GENOMICS; VARIANTS; CYP2D6; BENCH;
D O I
10.1016/j.cll.2022.09.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:587 / 602
页数:16
相关论文
共 105 条
  • [1] Getting Pharmacogenomics Into the Clinic
    Abbasi, Jennifer
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (15): : 1533 - 1535
  • [2] 3D Printing in Personalized Drug Delivery
    Afsana
    Jain, Vineet
    Haider, Nafis
    Jain, Keerti
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (42) : 5062 - 5071
  • [3] Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
    Alagoz, O.
    Durham, D.
    Kasirajan, K.
    [J]. PHARMACOGENOMICS JOURNAL, 2016, 16 (02) : 129 - 136
  • [4] STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY
    ALEXANDERSON, B
    EVANS, DAP
    SJOQVIST, F
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686): : 764 - +
  • [5] Pharmacogenomics: "Noninferiority" Is Sufficient for Initial Implementation
    Altman, R. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 348 - 350
  • [6] [Anonymous], TRACK YOUR OWN HEALT
  • [7] [Anonymous], MINDSTRONG HLTH TAKE
  • [8] Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
    Bank, P. C. D.
    Swen, J. J.
    Guchelaar, H. J.
    [J]. BMC MEDICINE, 2019, 17 (1)
  • [9] Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
    Blagec, Kathrin
    Koopmann, Rudolf
    Crommentuijn-van Rhenen, Mandy
    Holsappel, Inge
    van der Wouden, Cathelijne H.
    Konta, Lidija
    Xu, Hong
    Steinberger, Daniela
    Just, Enrico
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    Samwald, Matthias
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2018, 25 (07) : 893 - 898
  • [10] Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility
    Bradley, Paul
    Shiekh, Michael
    Mehra, Vishaal
    Vrbicky, Keith
    Layle, Stacey
    Olson, Marilyn C.
    Maciel, Alejandra
    Cullors, Ali
    Garces, Jorge A.
    Lukowiak, Andrew A.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 96 : 100 - 107